Author Archives: Natalie Themm
Canyon Labs Open House
Canyon Labs Opens Expanded Facility
Intermountain Health Announces New Children’s Health President and Expands Leadership Role for Hospital President to Build on Legacy of Pediatric Excellence
Intermountain Health Announces New Children’s Health President and Expands Leadership Role for Hospital President to Build on Legacy of Pediatric Excellence
Seek Labs Unveils BioSeeker™
Bioseeker™ is the AI Discovery Engine Powering Seek Labs’ Mission to Outpace Disease with Faster, Smarter Global Health Solutions
Merit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer with SnapFix Technology
Thin-wall design with superior insertion and unique sheath-securement solution to support successful radial access procedures and may aid in reducing arterial spasm and occlusion
Purgo Scientific Appoints Veteran MedTech Leader as Chief Executive Officer
James A. Bowman brings decades of experience launching disruptive surgical innovations.
Quansys Biosciences Launches Q-View™ Imager Plus: Delivering Reproducible, high-impact ELISA Data with Ease
Quansys Biosciences Launches Q-View™ Imager Plus: Delivering Reproducible, high-impact ELISA Data with Ease
Improving Women’s Health: MobileODT Joins Liger Medical
Improving Women’s Health: MobileODT Joins Liger Medical
Wasatch Health Announces Structured Capital Fund
Utah Investment Firm Expands to Deliver Flexible Capital to Transformative Healthcare Companies
Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas, Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains
Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains
Nestmedic Selects Curavit Clinical Research as U.S. CRO Partner for Pioneering Prenatal Monitoring Trial
Nestmedic Selects Curavit Clinical Research as U.S. CRO Partner for Pioneering Prenatal Monitoring Trial
Microvascular Therapeutics Celebrates Major Achievements at ASE 2025 Scientific Sessions
Microvascular Therapeutics Celebrates Major Achievements at ASE 2025 Scientific Sessions
BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
